The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지

Case Study on Advanced Thymic Cancer Treated with Wheel Balanced Therapy

수레바퀴 암치료법을 시행한 흉선암 환자에 대한 증례보고

  • Lee, Jong-Ho (East-West Cancer Center, Dunsan Oriental Hospital of Dae-jeon University) ;
  • Park, Jae-Woo (East-West Cancer Center, Dunsan Oriental Hospital of Dae-jeon University) ;
  • Yoo, Hwa-Seung (East-West Cancer Center, Dunsan Oriental Hospital of Dae-jeon University) ;
  • Cho, Chong-Kwan (East-West Cancer Center, Dunsan Oriental Hospital of Dae-jeon University) ;
  • Lee, Yeon-Weol (East-West Cancer Center, Dunsan Oriental Hospital of Dae-jeon University)
  • 이종호 (대전대학교 둔산한방병원 동서암센터) ;
  • 박재우 (대전대학교 둔산한방병원 동서암센터) ;
  • 유화승 (대전대학교 둔산한방병원 동서암센터) ;
  • 조종관 (대전대학교 둔산한방병원 동서암센터) ;
  • 이연월 (대전대학교 둔산한방병원 동서암센터)
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background : Advanced thymic cancer still remains as an intractable disease. The survival rate of advanced thymic cancer could be increased through chemotherapy and radiation, but the results have not been satisfactory. Objectives : To see whether wheel balanced therapy (WBT) has the therapeutic effects or not on advanced thymic cancer patient. Methods : A patient diagnosed with progression of thymic carcinoma with pleura metastasis visited the East-West Cancer Center (EWCC) on Feb 9th, 2011. The patient was treated with WBT for a period of 9 weeks from Feb 9th to Apr 16th. She stayed 6 weeks in hospital and took oriental medicine prescribed by EWCC. Computed tomography (CT) and blood test were used to evaluate the disease progression of the patient. Results : Mass of chest CT was stable for 2 months. The patient's quality of life improved during her hospital stay. Conclusions : This case study supports WBT may have efficacy in treating advanced thymic cancer patients.

Keywords

References

  1. Park IK, Kim DJ, Kim KD, Bae MK, Chung KY. Prognostic Factors of Thymic Carcinoma. Korean J Thorac Cardiovasc Surg 2005;38(8) :564-9.
  2. H Kunitoh, T Tamura, T Shibata, K Nakagawa, K Takeda, Y Nishiwaki, et al. A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial. British J of Cancer 2009;101(9):1549-54. https://doi.org/10.1038/sj.bjc.6605347
  3. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac surg 2004;77(5):1860-9. https://doi.org/10.1016/j.athoracsur.2003.10.001
  4. Blumberg D, Burt ME, Bains MS, Downey RJ, Martini N, Rusch V, et al. Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiocasc Surg 1998;115(2):303-8 https://doi.org/10.1016/S0022-5223(98)70273-9
  5. Hsu CP, Chen CT, Chen CL, Lin CT, Hsu NY, Wang JH, et al. Thymic carcinoma. Ten years' experience in twenty patients. J Thorac Cardiovasc Surg 1994;107(2):615-20.
  6. Yoo HS, Cho CK, Hong MS. Review of the best case series methodology: best case series results of East-West Cancer Center. Integr Cancer Ther 2008;7(3):182-8. https://doi.org/10.1177/1534735408322844
  7. Park JS, Yoo HS, Lee YW, Cho JH, Son CG, Cho CK. Wheel Balance Cancer Therapy in the treatment of metastatic gastric carcinoma : A retrospective analysis of 62 patients. Korean J Orient Int Med 2007;28(3):531-43.
  8. Park BK, Yoo HW, Lee YW, Han SS, Cho JH, Son CG, Cho CK. Retrospective Cohort Analysis for Lung Cancer Patients Treated with Wheel Balance Therapy (WBT). Korean J Orient Int Med 2009;19(2):45-56.
  9. Park HM, Kim SY, Jung IC, Lee YW, Cho CK, Yoo HS. Integrative Tumor Board: A Case Report and Discussion From East-West Cancer Center. Integr Cancer Ther 2010;9(2) :236-45. https://doi.org/10.1177/1534735410371479
  10. Lim C, Sung SW, Kim JH. Clinical analysis of surgical treatment and risk factors of thymoma. Koran J Thorac Cardiovase Surg 1997;30(1) :67-71.
  11. Kang SS, Chun MS, Kim YH, Park SI, Eom DW, Ro JY. Prognostic Relevance of WHO Classification and Masaoka Stage in Thymoma, Korean J Thorac Cardiovasc Surg 2005;38(1) :44-9.
  12. Lardinois D, Rechsteiner R, Lang RH, Gugger M, Betticher D, von Briel C, et al. Prognostic relevance of masaoka and muller-hermelink classification in patients with thymic tumors. Ann Thorac Surg 2000;69(5):1550-5. https://doi.org/10.1016/S0003-4975(00)01140-1
  13. Ogawa K, Uno T, Toita T, Onishi H, Yoshida H, Kakinohana Y, et al. Postoperative radiotherapy for patients with completely resected thymoma. Cancer 2002;94(5):1405-13. https://doi.org/10.1002/cncr.10373
  14. Loehrer PJ Sr, Jiroutek M, Aisner S, Aisner J, Green M, Thomas CR Jr, et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 2001;91(11):2010-5. https://doi.org/10.1002/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2
  15. Yoo HS, Lee YY, Song KC, Choi BL, Seo SH, Cho JH, et al. The effects of HangAmDan on antimetastasis and preventing relapses, administered to 69 cancer patients. Korean J Orient Int Med 2002:23(2):165-73.
  16. Park JS, Yoo HS, Lee YW, Cho JH, Son CG, Cho CK. Wheel Balance Cancer Therapy in the treatment of metastatic gastric carcinoma : A retrospective analysis of 62 patients. Korean J Orient Int Med 2007;28(3):531-43.
  17. Lee DE, Lee SY, Kim JS, Cho CK, Yoo HS, Choi SJ. Antitumor effect of Hang-Am-Dan (HAD) and its ingredients on Calu6 and MCF-7 human cacner cell lines. Korean J Orient Int Med 2009;30(5):50-60.
  18. Lee HJ, Kim JS, Yoon JW, Lee YW, Cho CK, Yoo HS, et al. Toxicological study on HangAmDan-B in Mice. J Acupunct Meridian Stud 2011;4(1) :54-60. https://doi.org/10.1016/S2005-2901(11)60007-1
  19. Son CG, Shin JW, Cho JH, Cho CK, Yun CH, Chung W, et al. Macrophage activation and nitric oxide production by water soluble components of Hericium erinaceum. Int Immunopharmacol 2006;6(8):1363-9. https://doi.org/10.1016/j.intimp.2006.03.005
  20. Yim MH, Shin JW, Son JY, Oh SM, Han SH, Cho JH, et, al. Soluble components of Hericium erinaceum induce NK cell activation via production of interleukin-12 in mice splenocytes. Acta Pharmacol Sin 2007;28(6):901-7. https://doi.org/10.1111/j.1745-7254.2007.00577.x
  21. Zheng HM. Evidence Based Approach of Wheel Balance Cancer Therapy; A Review [dissertation]. Daejeon University; 2011.